Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
nSEPIA aims to bring structure to an area long dominated by subjectivity
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Subscribe To Our Newsletter & Stay Updated
